AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Capecitabine in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Capetero 500 Tablets** Tablet | B4-4343 | Hetero Labs Nigeria Limited | active | 5 Jul 2028 |
| Capecitabine Tablets** Tablet | C4-1625 | Novartis Nigeria Limited | active | 24 Feb 2026 |
Capecitabine — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Capecitabine, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Capecitabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.